EQUITY RESEARCH MEMO

Med Institute

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Med Institute is a US-based medical device services company founded in 2016 and headquartered in West Lafayette, Indiana. The company offers comprehensive product development services designed to accelerate the path to market for medical devices, with a strong emphasis on safety and efficacy. Its capabilities span engineering, testing, regulatory affairs, clinical trials, and MRI safety, positioning it as a one-stop partner for medical device innovators. By leveraging deep expertise in regulatory pathways and clinical evidence generation, Med Institute helps clients navigate complex approval processes, reducing time-to-market and development costs. As a private, pre-clinical stage company, it has not disclosed funding or valuation, but its service-based model generates revenue through client engagements rather than product sales. Med Institute's value proposition lies in its ability to de-risk device development for clients, particularly in the highly regulated medtech landscape. The company is well-positioned to benefit from increasing outsourcing trends in the medical device industry, as smaller innovators seek specialized expertise without building in-house capabilities. While Med Institute does not develop its own products, its success is tied to the approval and commercialization of client devices. Key growth drivers include expanding its service offerings, forming strategic partnerships with large device manufacturers, and building a track record of successful regulatory submissions. The company's focus on MRI safety and other niche areas provides differentiation in a competitive services market.

Upcoming Catalysts (preview)

  • Q3 2026Announcement of strategic partnership with a top-10 medical device company60% success
  • Q4 2026Expansion of testing facilities or new lab opening70% success
  • Q2 2026Client device receives FDA clearance or CE mark with Med Institute's involvement50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)